1Cheruku KK, Ghani A, Ahmad F, et al. Efficacy of nonsteroidal anti-inflammatory medications for prevention of atrial fibrillation following coronary artery bypass surgery. Prev Cardiol, 2004,7:11-16.
2Dernellis JM, Paneratou MP. Relationship between C-reactive protein concentrations during glucocorticoid therapy and recurrent atrial fibrillation. Eur Heart J, 2004,25:1100-1107.
3Klein RM, Vester EG, Brehm MU,et al. Inflammation of the myocardium as an arrhythmia trigger. Z Kardiol, 2000,89(Suppl 3):24-35.
4Frustaci A, Caldarulo M, Buffon A, et al. Cardiac biopsy in patients with "primary" atrial fibrillation. Histologic evidence of occult myocardial diseases. Chest, 1991, 100:303-306.
5Mold C, Gewurz H, Du Clos TW. Regulation of complement activation by C-reactive protein. Immunopharmacology, 1999,42:23-30.
6Hack CE, Wolbink GJ, Schalkwijk C, et al. A role for secretory phospholipase A2 and C-reactive protein in the removal of injured cells. Immunol Today, 1997,18:111-115.
7Lai LP, Su MJ, Lin JL, et al. Down-regulation of L-type calcium channel and sarcoplasmic reticular Ca(2+)-ATPase mRNA in human atrial fibrillation without significant change in the mRNA of ryanodine receptor, calsequestrin and phospholamban: an insight into the mechanism of atrial electrical remodeling. J Am Coll Cardiol, 1999,33:1231-1237.
8Gaspo R, Bosch RF, Talajic M,et al. Functional mechanisms underlying tachycardia-induced sustained atrial fibrillation in a chronic dog model. Circulation, 1997,96:4027-4035.
9Allessie M, Ausma J, Schotten U. Electrical, contractile and structural remodeling during atrial fibrillation. Cardiovasc Res, 2002,54:230-246.
10Monica R, Luis M, Vanesa E, et al. Connective tissue growth factor is a mediator of angiotensin Ⅱ-induced fibrosis. Circulation, 2003,108:1499-1505.
5LAU Y F,YIU K H,SIU C W,et al.Hypertension andatrial fibrillation:epidemiology,pathophysiology andtherapeutic implications[J].J Hum Hypertens,2011,[Epub ahead of print].
6KING A.Arrhythmias:RAAS inhibition in atrial fibrilla-tion-one strike,but not out?[J].Nat Rev Cardiol,2011,8(5):242.
7SMIT M D,MAASS A H,DE JONG A M,et al.Role of inflammation in early atrial fibrillation recurrence[J].Europace,2012.
8PENA J M,MACFADYEN J,GLYNN R J,et al.High-sensitivity C-reactive protein,statin therapy,and risks of atrial fibrillation:an exploratory analysis of the JUPI-TER trial[J].Eur Heart J,2012,33(4):531-537.
10Fauchier L,Pierre B,de Labriolle A. Antiarrhythmic effect of statin therapy and atrial fibrillationa meta-analysis of randomized controlled trials[J].{H}Journal of the America College of Cardiology,2008,(8):828-835.
